My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

CVS Health Corp (NY:CVS)

77.72 -0.07 (-0.09%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9

...

58 59 Next >

3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now ↗

December 18, 2025

The stocks listed here trade at forward earnings multiples of less than 18.

Via The Motley Fool

2 Dividend Stocks to Buy for 2026 and Beyond ↗

December 18, 2025

The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks.

Via The Motley Fool

Humana, Molina Jump As House GOP Revolt Reignites Fight To Extend Obamacare Subsidies — Retail Warns ‘Healthcare Wreck’ ↗

December 17, 2025

Health insurance stocks split after a House GOP revolt revived debate over ACA subsidies, while a year-end extension was ruled out.

Via Stocktwits

CVS Health Corp (NYSE:CVS) Shows High Technical and Setup Ratings for Potential Breakout ↗

December 16, 2025

CVS Health Corp shows strong technical momentum and a perfect basing setup, signaling a potential breakout opportunity for chart-focused traders.

Via Chartmill

1 Healthcare Stock to Research Further and 2 That Underwhelm

December 15, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have...

Via StockStory

Topics Stocks

Small-Cap Surge Signals Major Market Rebalancing: Investors Pivot from Tech to Broader Economy

December 11, 2025

Small-capitalization stocks are currently experiencing an unprecedented surge, with the benchmark Russell 2000 index shattering all-time records in early December 2025. This remarkable rally, which saw...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

3 Reasons CVS is Risky and 1 Stock to Buy Instead

December 09, 2025

CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the...

Via StockStory

Topics Stocks

Meet the 2.5% Yield Dividend Stock That Could Soar in 2026 ↗

December 09, 2025

UnitedHealth Group raised its dividend in each of the last 16 years.

Via The Motley Fool

Glenview Capital Management Sells $71 Million of Alight Stake After Stock's 71% Drop ↗

December 09, 2025

Glenview Capital Management reduced its stake in Alight by roughly 16% during the third quarter.

Via The Motley Fool

Topics Regulatory Compliance

Why CVS Health (CVS) Stock Is Up Today

December 09, 2025

Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 3.2% in the morning session after the company raised its financial guidance for 2025 and provided a strong forecast for 2026 at its...

Via StockStory

Topics Artificial Intelligence

Glenview Doubles Down on Teva Stock With $72 Million Buy, According to Recent SEC Filing ↗

December 09, 2025

Glenview Capital Management added to its massive position in Teva Pharmaceuticals stock.

Via The Motley Fool

Topics Regulatory Compliance

1 S&P 500 Stock Worth Your Attention and 2 We Turn Down

December 07, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

2 Soaring Healthcare Stocks to Buy and Hold for a Decade ↗

December 04, 2025

HCA Healthcare and CVS Health are firing on all cylinders.

Via The Motley Fool

Q3 Earnings Review: Health Insurance Providers Stocks Led by CVS Health (NYSE:CVS)

December 03, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its...

Via StockStory

Topics Artificial Intelligence Economy Fraud

The State Street Consumer Staples ETF Offers Sharper Focus and Lower Costs Than The iShares US Consumer Staples ETF ↗

December 01, 2025

Expense ratios, sector focus, and portfolio makeup set these two consumer staples ETFs apart for investors seeking the right fit.

Via The Motley Fool

Topics ETFs

2 Large-Cap Stocks with Exciting Potential and 1 Facing Challenges

December 01, 2025

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Forget CVS, Buy This Healthcare Stock Instead ↗

November 28, 2025

This healthcare stock has struggled this year, but things are suddenly looking up.

Via The Motley Fool

Topics Government

3 Value Stocks We Keep Off Our Radar

November 20, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

CVS Pays $18.3 Million To Resolve Alleged Medi-Cal Billing Failures ↗

November 18, 2025

CVS agrees to an $18.3 million settlement resolving allegations it sought Medi-Cal reimbursement for prescriptions.

Via Benzinga

Health Insurance Providers Stocks Q3 Highlights: Cigna (NYSE:CI)

November 16, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Cigna (NYSE:CI) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Trump's Bond Buying Spree Surges Past $82 Million Since August ↗

November 15, 2025

Trump bought over $82 million in bonds, intersecting with sectors boosted by his policies. Disclosures show 175+ transactions.

Via Benzinga

Topics Bonds Government

Hedge Fund Sells $25.6 Million in Paramount Group Stock as Rithm's $1.6 Billion Deal Looms ↗

November 15, 2025

A surprising office-sector exit by a steady fund may reveal more about opportunity cost than pessimism.

Via The Motley Fool

Topics Regulatory Compliance

What One Hedge Fund's $29.6 Million Bet on First American Signals About the U.S. Housing Market ↗

November 15, 2025

One quiet hedge fund is making a contrarian move on a real-estate-linked stock just as the housing market starts to turn.

Via The Motley Fool

Why One Fund Just Invested $21 Million in This Once High-Flying Software Stock ↗

November 15, 2025

This hedge fund just made a bold move into a once-hyped software name that’s now trading at a steep discount.

Via The Motley Fool

Topics Regulatory Compliance

David Tepper's Contrarian Bet on UnitedHealth Group (UNH) Pays Off Amidst Market Volatility

November 13, 2025

In a move that has captured the attention of the financial world, legendary investor David Tepper, through his firm Appaloosa Management, made a significant contrarian bet on healthcare giant...

Via MarketMinute

Topics Economy

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. ↗

November 12, 2025

These companies are demonstrating their ability to deal with significant business risks.

Via The Motley Fool

3 Stocks That Have Made Epic Comebacks in 2025 ↗

November 12, 2025

Last year was a bad one for these stocks, but buying them on weakness would have proven to be a great move for investors.

Via The Motley Fool

Topics Government

A Look Into CVS Health Inc's Price Over Earnings ↗

November 12, 2025

Via Benzinga

Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch ↗

November 12, 2025

Eli Lilly to drop CVS Health's drug benefit plan and move to Rightway in 2026 as Novo Nordisk cuts Wegovy prices in India to defend market share.

Via Benzinga

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗

November 12, 2025

Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

58 59 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.